Audio Gap] here at the Bank of America Healthcare Conference. We're kicking off our very first session of the very first day. It's my pleasure to have with me Scholar Rock as our first presenting ...
Sanofi’s protein-based vaccine Nuvaxovid has conquered Moderna’s next-generation messenger RNA shot mNexspike in a head-to-head trial assessing the tolerability of the two COVID vaccines. In the phase ...
LONDON, April 23 (Reuters) - Sanofi (SASY.PA), opens new tab beat first-quarter estimates on Thursday as demand for its asthma and eczema drug Dupixent remained high, though analysts looked to ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Sanofi's new chief executive, Belén Garijo, will see her tenure at the company kick-started by a strong 2026 first quarter, with a healthy rise in revenues driven by immunology blockbuster Dupixent ...
As Sanofi counts down the days before its new leader arrives, the French pharma’s chief financial officer acknowledged there had been a “certain number of setbacks” under Paul Hudson’s tenure. When ...
Normally on Big Pharma earnings calls, execs are eager to talk up their new launches and tout blockbuster expectations. But during Sanofi’s first-quarter presentation, a patent defense took center ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
The FDA has extended its review of a new subcutaneous formulation of Sanofi's multiple myeloma therapy Sarclisa – which has long played second fiddle to Johnson & Johnson's blockbuster rival Darzalex ...
On April 23, Sanofi will report its results for the first quarter of 2026. As a reminder, its revenue grew 23.1% year-over-year to $13.53 billion in Q4 last year. Meanwhile, Sanofi’s non-GAAP P/E ...
Paul Hudson. photo credit Sanofi. PARIS - Sanofi is giving its top executive the boot. The French pharmaceutical giant with a production site in Monroe County, Pa., announced on Thursday that Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results